Status:
UNKNOWN
Melatonin in ADHD and Sleep Problems
Lead Sponsor:
Allan Hvolby
Collaborating Sponsors:
Sygehus Lillebaelt
Conditions:
Attention Deficit Hyperactivity Disorder
Sleep Disorder
Eligibility:
All Genders
6-13 years
Phase:
PHASE4
Brief Summary
Treatment with melatonin is often initiated on an insufficient basis as it has not been established prior to starting the treatment whether or not the child had delayed release of endogenous melatonin...
Eligibility Criteria
Inclusion
- Children aged 6-13 years referred to the child and adolescent psychiatric department for examination/treatment for ADHD
- Verified Cronical Sleep Problems
- Measured Dim Light Melatonin Onset
Exclusion
- IQ below 70
- Autism Disorder
- Actual or former treated with Melatonin
- Allergy to melatonin
Key Trial Info
Start Date :
September 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2024
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04318067
Start Date
September 1 2020
End Date
November 1 2024
Last Update
May 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Child and Adolescent Psychiatric department
Esbjerg, Denmark, 6715